Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-029755
Filing Date
2024-12-18
Accepted
2024-12-18 17:01:14
Documents
2
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 form3-12182024_101212.html 3  
1 form3-12182024_101212.xml 3 7735
2 ex24-12182024_101212.htm EX-24 7991
  Complete submission text file 0001415889-24-029755.txt   17189
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FIBROGEN, INC. 350 BAY STREET, SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address
DeLucia David (Reporting) CIK: 0002040705 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36740 | Film No.: 241560108